Advanced search options

Advanced Search Options 🞨

Browse by author name (“Author name starts with…”).

Find ETDs with:

in
/  
in
/  
in
/  
in

Written in Published in Earliest date Latest date

Sorted by

Results per page:

Sorted by: relevance · author · university · dateNew search

You searched for subject:(Pfizer). Showing records 1 – 15 of 15 total matches.

Search Limiters

Last 2 Years | English Only

No search limiters apply to these results.

▼ Search Limiters


Technical University of Lisbon

1. Charrua, António Pedro da Silveira e Lorena Pinto. Equity research - Pfizer Inc.

Degree: 2017, Technical University of Lisbon

Mestrado em Finanças

Este projecto contém informaçao detalhada da Pfizer Inc. Este Relatório de Avaliação é uma continuação do processo de implementação de um novo… (more)

Subjects/Keywords: Equity Research; Valuation; Pharmaceutical; Pfizer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Charrua, A. P. d. S. e. L. P. (2017). Equity research - Pfizer Inc. (Thesis). Technical University of Lisbon. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/15918

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Charrua, António Pedro da Silveira e Lorena Pinto. “Equity research - Pfizer Inc.” 2017. Thesis, Technical University of Lisbon. Accessed March 04, 2021. https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/15918.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Charrua, António Pedro da Silveira e Lorena Pinto. “Equity research - Pfizer Inc.” 2017. Web. 04 Mar 2021.

Vancouver:

Charrua APdSeLP. Equity research - Pfizer Inc. [Internet] [Thesis]. Technical University of Lisbon; 2017. [cited 2021 Mar 04]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/15918.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Charrua APdSeLP. Equity research - Pfizer Inc. [Thesis]. Technical University of Lisbon; 2017. Available from: https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/15918

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Louisiana State University

2. Hotard, Rebecca Ann. Media framing of prescription drug coverage following a recall.

Degree: MMC, Mass Communication, 2006, Louisiana State University

 Direct-to-consumer advertising of prescription drugs receives significant attention from academic researchers. Advertising, however, is not the only way prescription drugs are discussed in the public… (more)

Subjects/Keywords: merck; pfizer

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hotard, R. A. (2006). Media framing of prescription drug coverage following a recall. (Masters Thesis). Louisiana State University. Retrieved from etd-03282006-160416 ; https://digitalcommons.lsu.edu/gradschool_theses/3950

Chicago Manual of Style (16th Edition):

Hotard, Rebecca Ann. “Media framing of prescription drug coverage following a recall.” 2006. Masters Thesis, Louisiana State University. Accessed March 04, 2021. etd-03282006-160416 ; https://digitalcommons.lsu.edu/gradschool_theses/3950.

MLA Handbook (7th Edition):

Hotard, Rebecca Ann. “Media framing of prescription drug coverage following a recall.” 2006. Web. 04 Mar 2021.

Vancouver:

Hotard RA. Media framing of prescription drug coverage following a recall. [Internet] [Masters thesis]. Louisiana State University; 2006. [cited 2021 Mar 04]. Available from: etd-03282006-160416 ; https://digitalcommons.lsu.edu/gradschool_theses/3950.

Council of Science Editors:

Hotard RA. Media framing of prescription drug coverage following a recall. [Masters Thesis]. Louisiana State University; 2006. Available from: etd-03282006-160416 ; https://digitalcommons.lsu.edu/gradschool_theses/3950


University of KwaZulu-Natal

3. Maharaj, Alishna. Talent retention in Pfizer SA-Biopharma.

Degree: Business administration, 2013, University of KwaZulu-Natal

 Businesses are currently operating in a fiercely competitive environment. Businesses must therefore employ strategies to differentiate themselves from their competitors. Thanks to modern technology, most… (more)

Subjects/Keywords: Business administration.; Talent management.; Retention.; Pfizer SA-Biopharma.

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Maharaj, A. (2013). Talent retention in Pfizer SA-Biopharma. (Thesis). University of KwaZulu-Natal. Retrieved from http://hdl.handle.net/10413/13525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Maharaj, Alishna. “Talent retention in Pfizer SA-Biopharma.” 2013. Thesis, University of KwaZulu-Natal. Accessed March 04, 2021. http://hdl.handle.net/10413/13525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Maharaj, Alishna. “Talent retention in Pfizer SA-Biopharma.” 2013. Web. 04 Mar 2021.

Vancouver:

Maharaj A. Talent retention in Pfizer SA-Biopharma. [Internet] [Thesis]. University of KwaZulu-Natal; 2013. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10413/13525.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Maharaj A. Talent retention in Pfizer SA-Biopharma. [Thesis]. University of KwaZulu-Natal; 2013. Available from: http://hdl.handle.net/10413/13525

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Leiden University

4. Burgers, L.E. Towards prevention of rheumatoid arthritis.

Degree: 2019, Leiden University

  Rheumatoid Arthritis (RA) is a chronic disease that can result in high morbidity and economic costs. Recent evidence has suggested that early agressive treatment… (more)

Subjects/Keywords: UCB Pharma; Pfizer; Reumafonds

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Burgers, L. E. (2019). Towards prevention of rheumatoid arthritis. (Doctoral Dissertation). Leiden University. Retrieved from http://hdl.handle.net/1887/67920

Chicago Manual of Style (16th Edition):

Burgers, L E. “Towards prevention of rheumatoid arthritis.” 2019. Doctoral Dissertation, Leiden University. Accessed March 04, 2021. http://hdl.handle.net/1887/67920.

MLA Handbook (7th Edition):

Burgers, L E. “Towards prevention of rheumatoid arthritis.” 2019. Web. 04 Mar 2021.

Vancouver:

Burgers LE. Towards prevention of rheumatoid arthritis. [Internet] [Doctoral dissertation]. Leiden University; 2019. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/1887/67920.

Council of Science Editors:

Burgers LE. Towards prevention of rheumatoid arthritis. [Doctoral Dissertation]. Leiden University; 2019. Available from: http://hdl.handle.net/1887/67920


Université du Québec à Montréal

5. Korrich, Oumayma. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.

Degree: 2010, Université du Québec à Montréal

 L'idée de cette recherche part du constat qu'il existe, encore aujourd'hui, de fortes inégalités d'accès aux médicaments entre le Nord et le Sud. Ces inégalités… (more)

Subjects/Keywords: GlaxoSmithKline (Firme); Pfizer Inc.; Accessibilité; Industrie pharmaceutique; Légitimité; Médicament; Trithérapie SIDA; Stratégie d'entreprise

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Korrich, O. (2010). Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. (Thesis). Université du Québec à Montréal. Retrieved from http://www.archipel.uqam.ca/3628/1/M11644.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Korrich, Oumayma. “Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.” 2010. Thesis, Université du Québec à Montréal. Accessed March 04, 2021. http://www.archipel.uqam.ca/3628/1/M11644.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Korrich, Oumayma. “Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.” 2010. Web. 04 Mar 2021.

Vancouver:

Korrich O. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. [Internet] [Thesis]. Université du Québec à Montréal; 2010. [cited 2021 Mar 04]. Available from: http://www.archipel.uqam.ca/3628/1/M11644.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Korrich O. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. [Thesis]. Université du Québec à Montréal; 2010. Available from: http://www.archipel.uqam.ca/3628/1/M11644.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université du Québec à Montréal

6. Hasbani, Marc. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.

Degree: 2008, Université du Québec à Montréal

 La théorie de la légitimité présente l'organisation comme une institution sociale. Son existence ainsi que son droit d'utiliser les ressources nécessaires à son fonctionnement lui… (more)

Subjects/Keywords: Pfizer Inc.; Analyse sémiotique; Industrie pharmaceutique; Légitimité organisationnelle; Rapport annuel; Art de conter

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hasbani, M. (2008). La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. (Thesis). Université du Québec à Montréal. Retrieved from http://www.archipel.uqam.ca/1749/1/M10701.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hasbani, Marc. “La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.” 2008. Thesis, Université du Québec à Montréal. Accessed March 04, 2021. http://www.archipel.uqam.ca/1749/1/M10701.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hasbani, Marc. “La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.” 2008. Web. 04 Mar 2021.

Vancouver:

Hasbani M. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. [Internet] [Thesis]. Université du Québec à Montréal; 2008. [cited 2021 Mar 04]. Available from: http://www.archipel.uqam.ca/1749/1/M10701.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hasbani M. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. [Thesis]. Université du Québec à Montréal; 2008. Available from: http://www.archipel.uqam.ca/1749/1/M10701.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


University of Missouri – Kansas City

7. Baranes, Avraham Izhar. An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets.

Degree: PhD, 2016, University of Missouri – Kansas City

 This dissertation presents an examination of the pharmaceutical industry with a primary focus on the importance of intangible assets from the original institutional economics perspective.… (more)

Subjects/Keywords: Pharmaceutical industry; Intangible property; Pfizer Inc.; Dissertation  – University of Missouri – Kansas City  – Economics

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baranes, A. I. (2016). An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets. (Doctoral Dissertation). University of Missouri – Kansas City. Retrieved from http://hdl.handle.net/10355/49316

Chicago Manual of Style (16th Edition):

Baranes, Avraham Izhar. “An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets.” 2016. Doctoral Dissertation, University of Missouri – Kansas City. Accessed March 04, 2021. http://hdl.handle.net/10355/49316.

MLA Handbook (7th Edition):

Baranes, Avraham Izhar. “An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets.” 2016. Web. 04 Mar 2021.

Vancouver:

Baranes AI. An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets. [Internet] [Doctoral dissertation]. University of Missouri – Kansas City; 2016. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/10355/49316.

Council of Science Editors:

Baranes AI. An Original Institutionalist Approach to the Structure, Conduct, and Performance of the Pharmaceutical Industry: The Importance of Intangible Assets. [Doctoral Dissertation]. University of Missouri – Kansas City; 2016. Available from: http://hdl.handle.net/10355/49316


Université du Québec à Montréal

8. Korrich, Oumayma. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.

Degree: 2010, Université du Québec à Montréal

 L'idée de cette recherche part du constat qu'il existe, encore aujourd'hui, de fortes inégalités d'accès aux médicaments entre le Nord et le Sud. Ces inégalités… (more)

Subjects/Keywords: GlaxoSmithKline (Firme); Pfizer Inc.; Accessibilité; Industrie pharmaceutique; Légitimité; Médicament; Trithérapie SIDA; Stratégie d'entreprise

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Korrich, O. (2010). Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. (Thesis). Université du Québec à Montréal. Retrieved from http://archipel.uqam.ca/3628/1/M11644.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Korrich, Oumayma. “Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.” 2010. Thesis, Université du Québec à Montréal. Accessed March 04, 2021. http://archipel.uqam.ca/3628/1/M11644.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Korrich, Oumayma. “Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc.” 2010. Web. 04 Mar 2021.

Vancouver:

Korrich O. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. [Internet] [Thesis]. Université du Québec à Montréal; 2010. [cited 2021 Mar 04]. Available from: http://archipel.uqam.ca/3628/1/M11644.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Korrich O. Les réactions stratégiques de l'industrie pharmaceutique face aux controverses sur l'accès aux médicaments anti-Sida dans les pays les moins avancés : étude des cas GlaxoSmithKline et Pfizer Inc. [Thesis]. Université du Québec à Montréal; 2010. Available from: http://archipel.uqam.ca/3628/1/M11644.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Brno University of Technology

9. Kubiš, Martin. Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock.

Degree: 2019, Brno University of Technology

 The aim of this master`s thesis is to perform fundamental analysis and determine the intrinsic value of Pfizer Inc share. There are three main parts… (more)

Subjects/Keywords: Fundamentální analýza; akcie; investice; vnitřní hodnota; Pfizer Inc.; dividendové diskontní modely; ziskové modely; cash flow modely; historické modely; Fundamental analysis; share; investment; intrinsic value; Pfizer Inc.; dividend discount models; profit models; cash flow models; historical models

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Kubiš, M. (2019). Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock. (Thesis). Brno University of Technology. Retrieved from http://hdl.handle.net/11012/33451

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Kubiš, Martin. “Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock.” 2019. Thesis, Brno University of Technology. Accessed March 04, 2021. http://hdl.handle.net/11012/33451.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Kubiš, Martin. “Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock.” 2019. Web. 04 Mar 2021.

Vancouver:

Kubiš M. Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock. [Internet] [Thesis]. Brno University of Technology; 2019. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/11012/33451.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Kubiš M. Fundamentální analýza vybrané akcie: Fundamental Analysis of Selected Stock. [Thesis]. Brno University of Technology; 2019. Available from: http://hdl.handle.net/11012/33451

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Université du Québec à Montréal

10. Hasbani, Marc. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.

Degree: 2008, Université du Québec à Montréal

 La théorie de la légitimité présente l'organisation comme une institution sociale. Son existence ainsi que son droit d'utiliser les ressources nécessaires à son fonctionnement lui… (more)

Subjects/Keywords: Pfizer Inc.; Analyse sémiotique; Industrie pharmaceutique; Légitimité organisationnelle; Rapport annuel; Art de conter

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Hasbani, M. (2008). La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. (Thesis). Université du Québec à Montréal. Retrieved from http://archipel.uqam.ca/1749/1/M10701.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Hasbani, Marc. “La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.” 2008. Thesis, Université du Québec à Montréal. Accessed March 04, 2021. http://archipel.uqam.ca/1749/1/M10701.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Hasbani, Marc. “La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique.” 2008. Web. 04 Mar 2021.

Vancouver:

Hasbani M. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. [Internet] [Thesis]. Université du Québec à Montréal; 2008. [cited 2021 Mar 04]. Available from: http://archipel.uqam.ca/1749/1/M10701.pdf.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Hasbani M. La gestion de la légitimité par le récit : le cas de l'industrie pharmaceutique. [Thesis]. Université du Québec à Montréal; 2008. Available from: http://archipel.uqam.ca/1749/1/M10701.pdf

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Technical University of Lisbon

11. Baião, Marcos Miguel Lourenço dos Santos. Equity Research - Pfizer Inc.

Degree: 2015, Technical University of Lisbon

Mestrado em Finanças

A Pfizer Inc é uma empresa líder no desenvolvimento e comercialização de produtos biofarmacêuticos com um portfólio global que inclui medicamentos e… (more)

Subjects/Keywords: Avaliação de Empresas; Cash Flow Atualizado; Valor da Empresa; Free Cash Flow to the Firm; Avaliação Relativa; Pfizer; Company Valuation; Discounted Cash Flow; Relative Valuation

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Baião, M. M. L. d. S. (2015). Equity Research - Pfizer Inc. (Thesis). Technical University of Lisbon. Retrieved from https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/10705

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Baião, Marcos Miguel Lourenço dos Santos. “Equity Research - Pfizer Inc.” 2015. Thesis, Technical University of Lisbon. Accessed March 04, 2021. https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/10705.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Baião, Marcos Miguel Lourenço dos Santos. “Equity Research - Pfizer Inc.” 2015. Web. 04 Mar 2021.

Vancouver:

Baião MMLdS. Equity Research - Pfizer Inc. [Internet] [Thesis]. Technical University of Lisbon; 2015. [cited 2021 Mar 04]. Available from: https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/10705.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Baião MMLdS. Equity Research - Pfizer Inc. [Thesis]. Technical University of Lisbon; 2015. Available from: https://www.rcaap.pt/detail.jsp?id=oai:www.repository.utl.pt:10400.5/10705

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Universidad de Chile

12. Verdina Gacitúa, Ximena María. Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico.

Degree: 2007, Universidad de Chile

 Esta práctica profesional para optar al título de químico farmacéutico se realizó en el Departamento Médico del Laboratorio Pfizer, específicamente en las áreas de Información… (more)

Subjects/Keywords: Química y Farmacia; Laboratorio Pfizer de Chile; Servicios de información sobre medicamentos

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Verdina Gacitúa, X. M. (2007). Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico. (Thesis). Universidad de Chile. Retrieved from http://repositorio.uchile.cl/tesis/uchile/2007/verdina_x/html/index-frames.html; http://repositorio.uchile.cl/handle/2250/105636

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Verdina Gacitúa, Ximena María. “Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico.” 2007. Thesis, Universidad de Chile. Accessed March 04, 2021. http://repositorio.uchile.cl/tesis/uchile/2007/verdina_x/html/index-frames.html; http://repositorio.uchile.cl/handle/2250/105636.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Verdina Gacitúa, Ximena María. “Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico.” 2007. Web. 04 Mar 2021.

Vancouver:

Verdina Gacitúa XM. Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico. [Internet] [Thesis]. Universidad de Chile; 2007. [cited 2021 Mar 04]. Available from: http://repositorio.uchile.cl/tesis/uchile/2007/verdina_x/html/index-frames.html; http://repositorio.uchile.cl/handle/2250/105636.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Verdina Gacitúa XM. Servicio de información médica y farmacovigilancia en un laboratorio farmacéutico. [Thesis]. Universidad de Chile; 2007. Available from: http://repositorio.uchile.cl/tesis/uchile/2007/verdina_x/html/index-frames.html; http://repositorio.uchile.cl/handle/2250/105636

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation


Jönköping University

13. Stålstedt, Erik. Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry.

Degree: Economics, 2006, Jönköping University

Denna uppsats är skriven inom området finansiering och behandlar fenomenet uppköp och företagsförvärv inom läkemedelsbranschen. I uppsatsen undersöker man läkemedelsbranschen och några nyckelaffärer utförda… (more)

Subjects/Keywords: Mergers & Acquisitions; Pharmaceutical industry; Shareholders; Arbitrage Pricing Theory; share performance; Pfizer; Bristol-Myers Squibb and GlaxoSmithKline; Arbitrage Pricing Theory; aktieresultat; Pfizer; Bristol-Myers Squibb and GlaxoSmithKline; Sammanslagningar och förvärv; Läkemedelsbranschen; Aktieägare; Business and economics; Ekonomi

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Stålstedt, E. (2006). Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry. (Thesis). Jönköping University. Retrieved from http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-391

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Stålstedt, Erik. “Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry.” 2006. Thesis, Jönköping University. Accessed March 04, 2021. http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-391.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Stålstedt, Erik. “Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry.” 2006. Web. 04 Mar 2021.

Vancouver:

Stålstedt E. Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry. [Internet] [Thesis]. Jönköping University; 2006. [cited 2021 Mar 04]. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-391.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Stålstedt E. Mergers & Acquisitions : Abnormal returns in the pharmaceutical industry. [Thesis]. Jönköping University; 2006. Available from: http://urn.kb.se/resolve?urn=urn:nbn:se:hj:diva-391

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

14. Gómez Afanador, Juanita. Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A.

Degree: 2003, Universidad de los Andes

Subjects/Keywords: Pfizer S.A - Finanzas; Administración del conocimiento - Colombia - Estudio de casos; Capital intelectual; Administración financiera - Colombia - Estudio de casos

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Gómez Afanador, J. (2003). Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A. (Thesis). Universidad de los Andes. Retrieved from http://hdl.handle.net/1992/15978

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Gómez Afanador, Juanita. “Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A.” 2003. Thesis, Universidad de los Andes. Accessed March 04, 2021. http://hdl.handle.net/1992/15978.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Gómez Afanador, Juanita. “Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A.” 2003. Web. 04 Mar 2021.

Vancouver:

Gómez Afanador J. Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A. [Internet] [Thesis]. Universidad de los Andes; 2003. [cited 2021 Mar 04]. Available from: http://hdl.handle.net/1992/15978.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Gómez Afanador J. Diseño de un modelo de valoración del capital intelectual para mejorar la gestión de la división financiera del Laboratorio Farmaceutico PFIZER S.A. [Thesis]. Universidad de los Andes; 2003. Available from: http://hdl.handle.net/1992/15978

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

15. Brunstein, Daiana. Estructura óptima de capital.

Degree: Maestría en Finanzas, 2017, Universidad Torcuato di Tella

 The purpose of this paper is to examine the evolution of the capital structure theories of companies that emerged towards the end of the 1950's.… (more)

Subjects/Keywords: Análisis financiero; Análisis comparativo; TripAdvisor, Inc.; Yahoo! Inc.; Facebook; Amazon; Apple; Netflix; Wal-Mart; Whole Foods Market; CVS Health Corporation; Chevron; Johnson & Johnson; The Procter and Gamble; The Coca Cola Company; Pfizer; Nordstrom Inc.; Tesis; Teoría tradicional de la estructura de capital óptima; Teoría de Modigliani-Miller; Teoría del equilibro estático; Teoría del pecking-order

Record DetailsSimilar RecordsGoogle PlusoneFacebookTwitterCiteULikeMendeleyreddit

APA · Chicago · MLA · Vancouver · CSE | Export to Zotero / EndNote / Reference Manager

APA (6th Edition):

Brunstein, D. (2017). Estructura óptima de capital. (Thesis). Universidad Torcuato di Tella. Retrieved from http://repositorio.utdt.edu/handle/utdt/6628

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Chicago Manual of Style (16th Edition):

Brunstein, Daiana. “Estructura óptima de capital.” 2017. Thesis, Universidad Torcuato di Tella. Accessed March 04, 2021. http://repositorio.utdt.edu/handle/utdt/6628.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

MLA Handbook (7th Edition):

Brunstein, Daiana. “Estructura óptima de capital.” 2017. Web. 04 Mar 2021.

Vancouver:

Brunstein D. Estructura óptima de capital. [Internet] [Thesis]. Universidad Torcuato di Tella; 2017. [cited 2021 Mar 04]. Available from: http://repositorio.utdt.edu/handle/utdt/6628.

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

Council of Science Editors:

Brunstein D. Estructura óptima de capital. [Thesis]. Universidad Torcuato di Tella; 2017. Available from: http://repositorio.utdt.edu/handle/utdt/6628

Note: this citation may be lacking information needed for this citation format:
Not specified: Masters Thesis or Doctoral Dissertation

.